Sort
10,766 grants matching “checkpoint inhibitor”
Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies
$527,981Wei Zhang · Wake Forest University Health Sciences · R01 · FY2024 · CA
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
$527,973Howard C Crawford · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
$527,973Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · U01 · FY2021 · CA
A PHASE I TRIAL OF AN IMMUNE CHECKPOINT INHIBITOR PLUS STEREOTACTIC ABLATIVE RADIOTHERAPY IN PATIENTS WITH INOPERABLE STAGE I NON-SMALL CELL LUNG CAN
$527,936University Of California, Davis · · FY2015 · Department of the Army
Uncover the role of H3.3-G343R mutation in shaping the DNA damage response, anti-tumor immunity and mechanisms of resistance in glioma.
$527,929Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2022 · NS
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$527,799Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2023 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2019 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2021 · CA
Predictive experiment-based multiscale models of the tumor immune microenvironment and immunotherapy in breast cancer
$527,792Aleksander S. Popel · Johns Hopkins University · R01 · FY2020 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$527,746Gordon B. Mills · Oregon Health & Science University · U01 · FY2025 · CA
Translation of commensal bacteria mechanism for immunotherapy
$527,560Howard C Hang · Scripps Research Institute, The · R01 · FY2024 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2025 · CA
MODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCER
$527,525Marco Ruella · University Of Pennsylvania · R37 · FY2022 · CA
Core B: Computational
$527,419Alan S Perelson · Boston College · P01 · FY2021 · AI
Stromal Regulation of Basal Cell Carcinoma Formation
$527,389Anthony E Oro · Stanford University · R01 · FY2024 · AR
Novel Radiomics for Predicting Response to Immunotherapy for Lung Cancer
$527,355Anant Madabhushi · Emory University · R01 · FY2025 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$527,354Albert Folch · University Of Washington · R01 · FY2023 · CA
An innate immune checkpoint in cancer immunotherapy
$527,107Carla Rothlin · Yale University · R01 · FY2020 · CA
Interrogating the response of the tumor microenvironment to combination immunotherapy using a microfluidic platform
$526,891Albert Folch · University Of Washington · R01 · FY2022 · CA
Sustaining Tissue Resident Memory T cells
$526,754Yina Hsing Huang · Dartmouth College · R01 · FY2023 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Chuan-Yuan Li · Duke University · R01 · FY2021 · CA
Targeting ATM to boost systemic effects of radiotherapy and immunotherapy
$526,563Yunyan Jennifer Jennifer Zhang · Duke University · R01 · FY2025 · CA
Angiopoietin-2/Tie2 signaling regulation of liver metastasis in pancreatic neuroendocrine tumors
$526,519Minah Kim · Columbia University Health Sciences · R37 · FY2025 · CA
Uncover the role of H3.3-G343R mutation in shaping the DNA damage response, anti-tumor immunity and mechanisms of resistance in glioma.
$526,149Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2023 · NS